Skip to main content
. 2018 May 29;9:727. doi: 10.3389/fimmu.2018.00727

Figure 5.

Figure 5

Overall survival (OS) (A) and progression-free survival (PFS) (B) by high or low PD-1+/CD8+ ratio tumor-infiltrating lymphocytes in the ADCTA group. Kaplan–Meier survival plots of OS and PFS of 14 patients with high PD-1+/CD8+ ratio compared to 13 patients with low PD-1+/CD8+ ratio patients.